Literature DB >> 15316405

Ear, nose and throat and respiratory manifestations of gastro-esophageal reflux disease: an increasing conundrum.

Joel E Richter1.   

Abstract

Although recent studies suggest that gastro-oesophageal reflux disease (GORD) may contribute frequently to ear, nose and throat (ENT) and respiratory diseases, the cause-and-effect relationship is far from proven. This article addresses this controversial topic, emphasising recent literature that raises concerns about the credibility of this association and our tests to make this diagnosis. The author believes that these extra-oesophageal symptoms suspected to be secondary to GORD are a conundrum, but selective use of aggressive proton-pump-inhibitor therapeutic trials may help to resolve this issue in our patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316405     DOI: 10.1097/00042737-200409000-00004

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  9 in total

1.  Optimal treatment of laryngopharyngeal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Edoardo Savarino; Andrea Nacci; Salvatore Osvaldo Romeo; Massimo Bellini; Vincenzo Savarino; Bruno Fattori; Santino Marchi
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

Review 2.  Guide to the use of proton pump inhibitors in adult patients.

Authors:  Vandana Boparai; Jaishree Rajagopalan; George Triadafilopoulos
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  Esophageal impedance recording: clinical utility and limitations.

Authors:  Woosuk Park; Michael F Vaezi
Journal:  Curr Gastroenterol Rep       Date:  2005-06

Review 4.  Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: treatment results.

Authors:  Jean Paul Galmiche
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?

Authors:  Nicola de Bortoli; Andrea Nacci; Edoardo Savarino; Irene Martinucci; Massimo Bellini; Bruno Fattori; Linda Ceccarelli; Francesco Costa; Maria Gloria Mumolo; Angelo Ricchiuti; Vincenzo Savarino; Stefano Berrettini; Santino Marchi
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

6.  Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough.

Authors:  Michael J Hersh; Gregory S Sayuk; C Prakash Gyawali
Journal:  J Clin Gastroenterol       Date:  2010-04       Impact factor: 3.062

7.  Defining the relationship between gastroesophageal reflux and cough: probabilities, possibilities and limitations.

Authors:  Matthew M Eastburn; Peter H Katelaris; Anne B Chang
Journal:  Cough       Date:  2007-03-20

8.  Evidence of Pepsin-Related Ocular Surface Damage and Dry Eye (PROD Syndrome) in Patients with Laryngopharyngeal Reflux.

Authors:  Rocco Plateroti; Marta Sacchetti; Giuseppe Magliulo; Andrea Maria Plateroti; Annalisa Pace; Antonietta Moramarco; Alessandro Lambiase; Alice Bruscolini
Journal:  Life (Basel)       Date:  2020-09-15

9.  Laryngopharyngeal reflux in war-torn Syria and its association with smoking and other risks: an online cross-sectional population study.

Authors:  Mohammad Marwan Alhalabi; Ayham Alyousbashi; Ameer Kakaje; Aya Hamid; Yousef Mahmoud
Journal:  BMJ Open       Date:  2020-11-26       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.